ARDX Q4 2025 Earnings Explode: Biotech Growth Breakthrough

[ad_1] Ardelyx Inc. (NASDAQ: ARDX). ARDX Q4 2025 earnings delivered exceptional results. IBSRELA revenue surged 73% annually. Total company revenues reached $407.3 million. Indeed, the biotech company exceeded expectations with disciplined execution and expanded product adoption. Meanwhile, management provided confident…